SOLARA ACTIVE PHARMA SCIENCES LIMITED — Regulatory Filings 2021

Jun 3, 2021

==> picture [205 x 82] intentionally omitted <==

Communication Address: Solara Active Pharma Sciences Limited Batra Centre No. 28. Sardar Patel Road. Post Box 2630 Guindy. Chennai - 600 032. India Tel : +91 44 43446700. 22207500 Fax : +91 44 22350278 E-mail : investors@solara.com www.solara.co.in

June 3, 2021

The BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra-Kurla Complex Dalal Street, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 541540 Scrip Code: SOLARA Dear Sirs,

Sub: Disclosure of Related Party Transactions pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

With reference to above, please find enclosed the disclosure of Related Party Transactions, on consolidated basis, for the year ended March 31, 2021 drawn in accordance with applicable accounting standards.

We request you to kindly take the same on record.

Thanking you,

Yours faithfully,

For Solara Active Pharma Sciences Limited

S. Murali Krishna Company Secretary

Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636

REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942

Disclosure of Related party transactions on a Consolidated basis for the year ended 31st March 2021 (In pursuance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015)

Solara Active Pharma Sciences Limited Name of Related parties and Description of relationships

Person holding significant interest in the company and Promoter: Arun Kumar Pillai

Promoter and persons acting in concert: K R Ravishankar Deepa Arun Kumar Aditya Arun Kumar Tarini Arun Kumar Padmakumar Karunakaran Pillai Vineetha Mohanakumar Pillai Hemalatha Pillai Sajitha Pillai Rajitha Gopalakrishnan K R Lakshmi Yalavarthy Usha Rani Chayadeep Properties Pvt Ltd Karuna Ventures Private Limited Agnus Holdings Pvt Ltd Sequent Scientific Limited (upto April 08, 2021)* Pronomz Ventures LLP SRJR Enterprise LLP Karuna Business Solutions LLP Chayadeep Ventures LLP Agnus Capital LLP Devicam Capital LLP Triumph Venture Holdings LLP

• Company has filed an application with stock exchange for Reclassification of "Outgoing Promoters" from Promoter group to Public category on April 08, 2021.

Director and Key Management Personnel:
Bharath R. Sesha	Managing Director and Chief Executive Officer (Appointed as CEO wef. Feb 06, 2020 and appointed as MD wef. Aug 03, 2020 )
Jitesh Devendra	Managing Director (Resigned wef. August 03, 2020)
Subhash Anand	Executive Director- Finance and Chief Finance Officer (Appointed as CFO wef. Oct 30, 2020 and ED- Finance wef. Mar 31, 2021)
S Hariharan	Executive Director- Finance and Chief Finance Officer (Resigned as CFO wef. Oct 30, 2020 and ED- Finance wef. Mar 31, 2021)
R. Ramakrishnan	Independent Director
Nirmal P Bhogilal	Independent Director
Kausalya Santhanam	Independent Director
Deepak C Vaidya	Non-Executive Director
Ronald Tjeerd De Vries	Independent Director
Ankur Nand Thadani	Non-Executive Director
Arun Kumar Pillai	Person holding significant interest in the company
B Sreenivasa Reddy	Chief Operating Officer (Resigned wef. Oct 30, 2020)
Rajesh Salwan	Chief Operating Officer (Appointed wef. Oct 30, 2020)
S Murali Krishna	Company Secretary

Enterprises controlled, owned or significantly influenced by directors, key management personnel or person holding significant interest in the company:

Strides Pharma Science Limited, India Devendra Estates LLP, India (upto August 03, 2020) Alivira Animal Health Limited, India (upto April 08, 2021) Tenshi Life Sciences Private Limited, India Aurore Life Sciences Private Limited, India Tenshi Kaizen Private Limited, India Olene Life Sciences Private Limited, India GMS Tenshi Holdings Pte Limited, Singapore Stelis Biopharma Private Limited, India

Tenshi Pharmaceuticals Private Limited, India (formerly known as Steriscience Private Limited and Sovizen Life Sciences Private Limited) Hydra Active Pharma Sciences Private Limited, India (formerly known as Tenshi Active Pharma Sciences Private Limited) Velbiom Probiotics Private Limited, India (formerly known as Tenshi Life Care Private Limited) Triphase Pharmaceuticals Private Limited, India Outlook Therapeutics Inc, USA Naari Pharma Private Limited, India Sequent Research Limited, India Tenshi Kaizen Inc., USA Tenshi Kaizen USA Inc., USA Batliboi Impex Limited, India Tenshi Life Sciences Pte Ltd, Singapore Biolexis Pte Ltd, Singapore Navad Life Sciences Pte Ltd, Singapore Aurore Pharmaceuticals Private Limited, India Tenshi Kaizen Pharma Pte Ltd, Singapore Tenshi Kaizen Private Limited, UK Tenshi KSM Private Limited, India Steriscience Specialties Pvt Ltd, India (formerly known as Steriscience Pharma Pvt Ltd) Empyrean Life Sciences Pvt Ltd, India Steriscience Pte Limited, Singapore Steriscience BV, Netherlands Tenshi Kaizen B V, Netherlands Steriscience Specialties Sp. z.o.o, Poland Stelis Pte Ltd, Singapore Stelis Biopharma LLC, USA

Disclosure of Related party transactions on a Consolidated basis for the year ended 31st March 2021 (In pursuance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015)

Transactions during theyear	Rs. in Crores	Rs. in Crores	Rs. in Crores
Description	Related party	March 31, 2021
Sale of goods	Strides Pharma Science Limited	220.19
	Aurore Life Sciences Private Limited	3.29
	Tenshi Kaizen Private Limited	-
	Steriscience Specialties Pvt Ltd	0.13
	Alivira Animal Health Limited	20.91
Sale of services	Strides Pharma Science Limited	0.04
Interest income	Tenshi Life Sciences Private Limited	1.23
Commission income	Alivira Animal Health Limited	0.02
Other operatingrevenue	Strides Pharma Science Limited	2.09
Sale ofproperty, plant and equipment	Stelis Biopharma Private Limited	0.02
Other income	Tenshi Kaizen Private Limited	0.21
Purchase of goods	Alivira Animal Health Limited	3.21
	Sequent Scientific Limited	0.32
	Strides Pharma Science Limited	-
	Aurore Pharmaceuticals Private Limited	0.02
	Aurore Life Sciences Private Limited	10.63
Purchase of services	Sequent Research Limited	4.15
	Tenshi Kaizen Private Limited	2.50
	Batliboi Impex Limited	0.27
Purchase ofproperty, plant and equipment	Tenshi Life Sciences Private Limited	-
Recovery of expenses from	Alivira Animal Health Limited	-
	Sequent Research Limited	0.93
	Strides Pharma Science Limited	16.73
Reimbursement of expenses to	Strides Pharma Science Limited	2.45
	Tenshi Life Sciences Private Limited	1.84
	Sequent Scientific Limited	0.05
	Sequent Research Limited	0.23
Rental Income	Sequent Research Limited	0.95
Rent & Maintenance for leased property	Devendra estates LLP	0.10
	Strides Pharma Science Limited	1.60
Loangiven	Tenshi Life Sciences Private Limited	-
Loan / Advances refund received	Tenshi Life Sciences Private Limited	50.00
	Tenshi Kaizen Private Limited	10.50
Sitting fees paid to directors	Deepak C Vaidya	0.11
	Kausalya Santhanam	0.11
	Nirmal P Bhogilal	0.11
	Ronald Tjeerd De Vries	0.11
	R. Ramakrishnan	0.11
Remuneration to Non-executive directors	Deepak C Vaidya	0.10
	Kausalya Santhanam	0.10
	Nirmal P Bhogilal	0.10
	Ronald Tjeerd De Vries	0.10
	R. Ramakrishnan	0.10
Services received in the capacity other than as KMP (refer note (i) below)	Subhash Anand	0.13
	Rajesh Salwan	0.14
	Bharat R Sesha	-
Short term employee benefits paid to (refer note (i) below)	Jitesh Devendra	3.30
	S Hariharan	1.82
	Bharat R Sesha	5.67
	Subhash Anand	1.73
	Rajesh Salwan	1.13
	B Sreenivasa Reddy	1.39
	S Murali Krishna	0.45

note (i): The compensation excludes gratuity & compensated absences which cannot be separately identified from the composite amount advised by the actuary.